Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

712 works between 1965 and 2025
All (712) Journal Article (482) Book Chapter (6) Conference Publication (222) Other Outputs (2)

701 - 712 of 712 works

1991

Journal Article

ACUTE BUT NOT CHRONIC GASTRIC SODIUM ADMINISTRATION REGULATES VASOACTIVE-INTESTINAL-PEPTIDE METABOLISM BY THE LIVER

HAWLEY, CM, DUGGAN, KA, MACDONALD, GJ and SHELLEY, S (1991). ACUTE BUT NOT CHRONIC GASTRIC SODIUM ADMINISTRATION REGULATES VASOACTIVE-INTESTINAL-PEPTIDE METABOLISM BY THE LIVER. Acta Physiologica Scandinavica, 143 (3), 295-298. doi: 10.1111/j.1748-1716.1991.tb09235.x

ACUTE BUT NOT CHRONIC GASTRIC SODIUM ADMINISTRATION REGULATES VASOACTIVE-INTESTINAL-PEPTIDE METABOLISM BY THE LIVER

1991

Conference Publication

PREGNANCY AFTER RENAL-TRANSPLANTATION - OUTCOME AND EFFECT ON RENAL-FUNCTION

BURKE, , HARDIE, IR, MENZIES, B, PETRIE, JJ, RIGBY, R, HAWLEY, C and BOYLE, P (1991). PREGNANCY AFTER RENAL-TRANSPLANTATION - OUTCOME AND EFFECT ON RENAL-FUNCTION. CAMBRIDGE: BLACKWELL SCIENCE INC.

PREGNANCY AFTER RENAL-TRANSPLANTATION - OUTCOME AND EFFECT ON RENAL-FUNCTION

1991

Conference Publication

EARLY ISCHEMIC CARDIAC MORTALITY IN ELDERLY RENAL-ALLOGRAFT RECIPIENTS

CAREY, L, HAWLEY, C, MENZIES, B, PETRIE, J, RIGBY, R, BURKE, J, HARDIE, , WALL, D, STRONG, R, LYNCH, S, WOODRUFF, P and QUINN, J (1991). EARLY ISCHEMIC CARDIAC MORTALITY IN ELDERLY RENAL-ALLOGRAFT RECIPIENTS. CAMBRIDGE: BLACKWELL SCIENCE INC.

EARLY ISCHEMIC CARDIAC MORTALITY IN ELDERLY RENAL-ALLOGRAFT RECIPIENTS

1991

Journal Article

Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide

Hawley, CM, Duggan, KA, Macdonald, GJ and Shelley, S (1991). Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide. Clinical Science, 81 (1), 79-83. doi: 10.1042/cs0810079

Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide

1990

Conference Publication

THE EFFECT OF CYCLOSPORINE THERAPY ON CADAVER KIDNEY-TRANSPLANT RESULTS AT A SINGLE CENTER

HARDIE, IR, PETRIE, J, RIGBY, R, STRONG, R, WALL, D, LYNCH, S, HAWLEY, C, WOODRUFF, P and QUINN, J (1990). THE EFFECT OF CYCLOSPORINE THERAPY ON CADAVER KIDNEY-TRANSPLANT RESULTS AT A SINGLE CENTER. CAMBRIDGE: BLACKWELL SCIENCE INC.

THE EFFECT OF CYCLOSPORINE THERAPY ON CADAVER KIDNEY-TRANSPLANT RESULTS AT A SINGLE CENTER

1990

Journal Article

Onset of Dialysis Encephalopathy in Cyclosporine-Treated Renal Allograft Recipients

Hawley, CM, Rigby, RJ, Boyle, RS and Petrie, Jjb (1990). Onset of Dialysis Encephalopathy in Cyclosporine-Treated Renal Allograft Recipients. American Journal of Kidney Diseases, 15 (4), 364-368. doi: 10.1016/S0272-6386(12)80083-7

Onset of Dialysis Encephalopathy in Cyclosporine-Treated Renal Allograft Recipients

1989

Conference Publication

SODIUM - A REGULATOR OF VASOACTIVE INTESTINAL PEPTIDE (VIP) METABOLISM

HAWLEY, CM, SHELLEY, S, DUGGAN, KA and MACDONALD, GJ (1989). SODIUM - A REGULATOR OF VASOACTIVE INTESTINAL PEPTIDE (VIP) METABOLISM. CAMBRIDGE: BLACKWELL SCIENCE INC.

SODIUM - A REGULATOR OF VASOACTIVE INTESTINAL PEPTIDE (VIP) METABOLISM

1989

Journal Article

Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit

Duggan, K. A., Hawley, C. M., Macdonald, G. J. and Shelley, S. (1989). Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit. Journal of Physiology-London, 418 (1), 251-259. doi: 10.1113/jphysiol.1989.sp017838

Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit

1988

Journal Article

Improved Results After Liver-Transplantation - Queensland Liver-Transplant Program

Lynch, S, Kerlin, P, Ong, TH, Pillay, P, Wall, D, Balderson, G, Burrow, B, Board, J, Dyer, P, Wright, M, Debuse, P, Whiting, R, Clark, R, Cleghorn, G, Shepherd, R, Oconnor, J, Rigby, R, Petrie, J, Hardie, I, Hawley, C and Strong, R (1988). Improved Results After Liver-Transplantation - Queensland Liver-Transplant Program. Transplantation Proceedings, 20 (1), 34-37.

Improved Results After Liver-Transplantation - Queensland Liver-Transplant Program

1988

Conference Publication

RENAL AND MYOCARDIAL INFARCTS ASSOCIATED WITH SLE AND THE LUPUS INHIBITOR

BOYLE, P, CRASWELL, P, HAWLEY, C and SEARLE, J (1988). RENAL AND MYOCARDIAL INFARCTS ASSOCIATED WITH SLE AND THE LUPUS INHIBITOR. MALDEN: BLACKWELL SCIENCE INC.

RENAL AND MYOCARDIAL INFARCTS ASSOCIATED WITH SLE AND THE LUPUS INHIBITOR

1986

Journal Article

HEMODYNAMIC PROPERTIES OF BUCINDOLOL, A BETA-ADRENOCEPTOR BLOCKING DRUG WITH VASODILATOR ACTIVITY

BETT, N, DRYBURGH, L, BOYLE, C and HAWLEY, C (1986). HEMODYNAMIC PROPERTIES OF BUCINDOLOL, A BETA-ADRENOCEPTOR BLOCKING DRUG WITH VASODILATOR ACTIVITY. American Journal of Cardiology, 57 (8), 678-681. doi: 10.1016/0002-9149(86)90858-1

HEMODYNAMIC PROPERTIES OF BUCINDOLOL, A BETA-ADRENOCEPTOR BLOCKING DRUG WITH VASODILATOR ACTIVITY

1965

Journal Article

ANALYSIS OF THE WAITING LIST IN BRITISH-COLUMBIA

FOULKES, RG, HAWLEY, CM, HUGHES, AP and TISCHLER, B (1965). ANALYSIS OF THE WAITING LIST IN BRITISH-COLUMBIA. American Journal of Mental Deficiency, 70 (3), 413-422.

ANALYSIS OF THE WAITING LIST IN BRITISH-COLUMBIA

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au